Posts

Lilly to acquire biopharma firm Versanis for $1.9bn

Eli Lilly and Company has signed an agreement for the acquisition of biopharmace...

Fighting AMR with a value and subscription model 

The recent reintroduction of the Pasteur Act seeks to address the global threat ...

Futura Medical and Haleon partner to commercialise Erox...

UK-based Futura Medical has signed a deal with Haleon to commercialise its OTC e...

FDA expands Veklury’s use to Covid-19 patients with sev...

The move follows a positive decision made by the EMA earlier this year, broadeni...

Eleven and Novo Nordisk partner to develop nucleic acid...

The companies will develop new molecules using Eleven's innovative DELiveri plat...

SNIPR celebrates US court’s favourable ruling on CRISPR...

The US Federal Court overturned a previous ruling in the patent infringement cas...

Australian CAI unveils new facility for cancer therapy ...

The Centre for Advanced Imaging (CAI) of the University of Queensland in Austral...

Researchers turn to CRISPR to unlock one of the trickie...

Researchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alz...

STAT+: After FDA nod, Better Therapeutics races to boos...

In the latest edition of STAT's Health Tech newsletter: Better Therapeutics race...

Unimolecular reactions of anti-glycolaldehyde oxide and...

Criegee intermediates are produced in the ozonolysis of unsaturated compounds in...

5-aminolevulinic acid might help fight mitochondrial di...

Tokyo, Japan – Scientists from Tokyo Metropolitan University have shown that 5-a...

UVA engineer innovates a liquid safety cushioning techn...

The discovery that football players were unknowingly acquiring permanent brain d...

Renewal for university network Enlight

The European university network Enlight has been renewed: the EU has funded the ...

Incyte’s Opzelura Meets Primary Endpoint in Eczema Tria...

Incyte is attempting to enter the competitive market for atopic dermatitis with ...

Samsung Inks $391M Deal with Novartis Amidst Plans for ...

After an initial deal of $81 million in June 2022, Novartis and Samsung have dec...

FDA Warning Letter for Tablo Hemodialysis System

After experiencing trouble with observations in February, Outset Medical has rec...